Literature DB >> 12529396

Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality.

Thierry Buchou1, Muriel Vernet, Olivier Blond, Hans H Jensen, Hervé Pointu, Birgitte B Olsen, Claude Cochet, Olaf-Georg Issinger, Brigitte Boldyreff.   

Abstract

Protein kinase CK2 is a ubiquitous protein kinase implicated in proliferation and cell survival. Its regulatory beta subunit, CK2beta, which is encoded by a single gene in mammals, has been suspected of regulating other protein kinases. In this work, we show that knockout of the CK2beta gene in mice leads to postimplantation lethality. Mutant embryos were reduced in size at embryonic day 6.5 (E6.5). They did not exhibit signs of apoptosis but did show reduced cell proliferation. Mutant embryos were resorbed at E7.5. In vitro, CK2beta(-/-) morula development stopped after the blastocyst stage. Attempts to generate homozygous embryonic stem (ES) cells failed. By using a conditional knockout approach, we show that lack of CK2beta is deleterious for mouse ES cells and primary embryonic fibroblasts. This is in contrast to what occurs with yeast cells, which can survive without functional CK2beta. Thus, our study demonstrates that in mammals, CK2beta is essential for viability at the cellular level, possibly because it acquired new functions during evolution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529396      PMCID: PMC140710          DOI: 10.1128/MCB.23.3.908-915.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

Review 1.  Protein kinase CK2 and its role in cellular proliferation, development and pathology.

Authors:  B Guerra; O G Issinger
Journal:  Electrophoresis       Date:  1999-02       Impact factor: 3.535

2.  Interactions of protein kinase CK2beta subunit within the holoenzyme and with other proteins.

Authors:  M Kusk; R Ahmed; B Thomsen; C Bendixen; O G Issinger; B Boldyreff
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Searching interaction partners of protein kinase CK2beta subunit by two-hybrid screening.

Authors:  S Grein; K Raymond; C Cochet; W Pyerin; E M Chambaz; O Filhol
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha.

Authors:  J K Hériché; F Lebrin; T Rabilloud; D Leroy; E M Chambaz; Y Goldberg
Journal:  Science       Date:  1997-05-09       Impact factor: 47.728

5.  CDC5 and CKII control adaptation to the yeast DNA damage checkpoint.

Authors:  D P Toczyski; D J Galgoczy; L H Hartwell
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

Review 6.  Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation.

Authors:  L A Pinna; F Meggio
Journal:  Prog Cell Cycle Res       Date:  1997

7.  A-Raf kinase is a new interacting partner of protein kinase CK2 beta subunit.

Authors:  B Boldyreff; O G Issinger
Journal:  FEBS Lett       Date:  1997-02-17       Impact factor: 4.124

8.  The regulatory subunit of protein kinase CK2 is a specific A-Raf activator.

Authors:  C Hagemann; A Kalmes; V Wixler; L Wixler; T Schuster; U R Rapp
Journal:  FEBS Lett       Date:  1997-02-17       Impact factor: 4.124

9.  Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies.

Authors:  D Vittet; T Buchou; A Schweitzer; E Dejana; P Huber
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

10.  The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

Authors:  R Hakem; J L de la Pompa; C Sirard; R Mo; M Woo; A Hakem; A Wakeham; J Potter; A Reitmair; F Billia; E Firpo; C C Hui; J Roberts; J Rossant; T W Mak
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

View more
  116 in total

1.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 2.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

3.  Protein kinase CK2 modulates developmental functions of the abscisic acid responsive protein Rab17 from maize.

Authors:  Marta Riera; Mercè Figueras; Cristina López; Adela Goday; Montserrat Pagès
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

4.  Protein kinase CK2: a new view of an old molecular complex.

Authors:  Odile Filhol; Jean-Louis Martiel; Claude Cochet
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

5.  A homozygous mutant embryonic stem cell bank applicable for phenotype-driven genetic screening.

Authors:  Kyoji Horie; Chikara Kokubu; Junko Yoshida; Keiko Akagi; Ayako Isotani; Akiko Oshitani; Kosuke Yusa; Ryuji Ikeda; Yue Huang; Allan Bradley; Junji Takeda
Journal:  Nat Methods       Date:  2011-10-23       Impact factor: 28.547

6.  Protein kinase CK2 and new binding partners during spermatogenesis.

Authors:  Nadja Mannowetz; Sabine Kartarius; Gunther Wennemuth; Mathias Montenarh
Journal:  Cell Mol Life Sci       Date:  2010-06-04       Impact factor: 9.261

7.  Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes.

Authors:  Nadine Wilhelm; Katja Kostelnik; Claudia Götz; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2012-01-24       Impact factor: 3.396

8.  CK2 phosphorylation of eukaryotic translation initiation factor 5 potentiates cell cycle progression.

Authors:  Miwako Kato Homma; Ikuo Wada; Toshiyuki Suzuki; Junko Yamaki; Edwin G Krebs; Yoshimi Homma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-14       Impact factor: 11.205

9.  CK2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5'-terminal oligopyrimidine mRNA metabolism.

Authors:  Elena I Schwartz; Robert V Intine; Richard J Maraia
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor.

Authors:  P P Scaglioni; T M Yung; S Choi; S C Choi; C Baldini; G Konstantinidou; P P Pandolfi
Journal:  Mol Cell Biochem       Date:  2008-06-20       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.